Skip to content

Company K+S expands its reach...

K+S's rating has been downgraded from 'Buy' to 'Sell' by Berenberg, with the price target lowered from 17 to 11 euros. Simultaneously, UBS has retained its 'Sell' rating and set a price target of 11.50 euros.

K+S expands its offerings now.
K+S expands its offerings now.

Company K+S expands its reach...

In a recent development, both private bank Berenberg and UBS have advised against purchasing shares of the fertilizer producer, K+S. This advice comes in light of the company's weak chart and the new analyst, Sebastian Bray, expecting a decrease in agricultural commodity prices by 2026.

Bray, who is now responsible for K+S stock, believes that in a scenario of decreasing agricultural commodity prices, there is "no plausible reason for a buy recommendation" for K+S. This pessimistic outlook has led to the significant lowering of the fair value for K+S shares from 17.00 to 11.00 euros.

UBS analyst Priyanka Patel had previously downgraded K+S to "Sell" on Monday, and Patel has maintained her cautious stance, keeping the fair value unchanged at 11.50 euros. Patel is particularly wary of K+S's financial performance, citing the challenging market environment as a major concern.

Market expectations for K+S's EBITDA for the coming year are considered somewhat too optimistic, and those already invested in K+S's stock are advised to observe the stop-loss at 11.70 euros. For 2027, market expectations for K+S's EBITDA could even be too confident.

It is not just the new analysts who are bearish on K+S. The investment rating for K+S has been significantly lowered from "Buy" to "Sell". A search for recent institutional changes in the stock recommendation for K+S shares did not yield any results, suggesting that the negative sentiment towards K+S may be widespread.

K+S has experienced significant discounting of MDAX shares due to disappointing second-quarter results. The company's shareholder, however, has maintained its assessment.

Despite the attractive valuation, it is not recommended to buy K+S shares due to the weak chart and the uncertain outlook for agricultural commodity prices. It seems that the road ahead for K+S may be challenging, and investors would be well-advised to tread carefully.

Read also:

Latest